Bazedoxifene is a third-generation selective estrogen receptor modulator currently in development as an option for the prevention and treatment of postmenopausal osteoporosis. This review provides a overview of bazedoxifene’s known clinical effects, and offers insight into how this new therapeutic agent may fit into the options available for postmenopausal women in the near future.